Continued high prevalence and adverse clinical impact of human immunodeficiency virus–associated sensory neuropathy in the era of combination antiretroviral …
Objective To provide updated estimates of the prevalence and clinical impact of human
immunodeficiency virus− associated sensory neuropathy (HIV-SN) and neuropathic pain
due to HIV-SN in the combination antiretroviral therapy (CART) era. Design Prospective,
cross-sectional analysis. Clinical correlates for HIV-SN and neuropathic pain, including age,
exposure to CART, CD4 levels, plasma viral load, hepatitis C virus infection, and alcohol use
disorders, were evaluated in univariate and multivariate models. Setting Six US academic …
immunodeficiency virus− associated sensory neuropathy (HIV-SN) and neuropathic pain
due to HIV-SN in the combination antiretroviral therapy (CART) era. Design Prospective,
cross-sectional analysis. Clinical correlates for HIV-SN and neuropathic pain, including age,
exposure to CART, CD4 levels, plasma viral load, hepatitis C virus infection, and alcohol use
disorders, were evaluated in univariate and multivariate models. Setting Six US academic …
